Department of Health and Human Services June 1, 2017 – Federal Register Recent Federal Regulation Documents
Results 1 - 12 of 12
A Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period
On September 15, 2016 the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), published a notice in the Federal Register announcing a public meeting and request for public comment on a draft testing protocol. Written comments were to be received by December 7, 2016. NIOSH initially extended the public comment period to June 7, 2017 [81 FR 88687]. NIOSH is extending the public comment period for a second time to August 30, 2017. The longer timeframe will allow companies to test the protocol with the proposed challenge agents.
Health Risks to Workers Associated With Occupational Exposures to Peracetic Acid; Extension of Comment Period
On March 7, 2017 the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), published a notice in the Federal Register announcing a request for information to evaluate the scientific and technical data on occupational exposure to peracetic acid (CAS #79-21-0, also known as peroxyacetic acid and PAA). Written comments were to be received by June 5, 2017. In response to a request from an interested party, NIOSH is extending the comment period until October 1, 2017.
Agency Information Collection Activities; Comment Request; Redesign of Existing Data Collection; Older Americans Act Titles III and VII; State Program Performance Report
The Administration for Community Living (ACL) is announcing an opportunity for the public to comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish a notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on a proposed revision to an existing data collection related to the Older Americans Act Title III and VII State Program Performance Report (SPR) (ICR Rev).
Prospective Grant of Exclusive Patent License: Mutant IDH1 Inhibitors Useful for Treating Cancer
National Center for Advancing Translational Sciences, an institute of the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the Patent Applications listed in the Summary Information section of this notice to GeneXion Oncology, Inc., located in New York, NY.
Announcement of the Award of One Single-Source Low-Cost Extension Supplement Grant Within the Office of Refugee Resettlement's Unaccompanied Children's Program
ACF, ORR, announces the award of one single-source low-cost extension supplement grant for a total of $93,597,707 under the UC Program.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.